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In light of several credible diet and cancer hypotheses, we suggest strategies for advancing our understanding in this area. Two conceptual
approaches can be taken in defining dietary exposure: the decompositional approach focuses on specific nutrients and other chemical constituents
of food, whereas the integrative approach emphasizes the action of whole foods or food patterns (cuisines). Diet-cancer hypotheses can be
organized according to this conceptual framework. We review four types of scientific investigation available to us for advancing the diet and cancer
field: metabolic (clinical nutrition) studies; animal studies; observational epidemiologic investigations; and clinical trials. Each of these designs has its
strengths and limitations. Observational epidemiologic studies and trials have the particular advantage of examining explicit cancer end points in
humans. Results from metabolic and animal research, however, can complement the findings from epidemiologic studies and trials. Finally, we
briefly review strategies for evaluating promising hypotheses linking diet to cancers of the large bowel, lung, breast, and prostate. - Environ Health
Perspect 103(Suppl 8):171-175 (1995)
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Introduction
It is clear from Willett's review (1) that we
have many credible hypotheses linking diet
to several major cancers. In this paper we
provide a briefcritical overview ofdifferent
research strategies in this area and suggest
particular studies likely to advance our
understanding ofthe connections between
diet and cancer.
Conceptualizing Diet
Because what people eat is so complex and
varied, we need some theoretical frame-
work for defining diet. Two alternative
conceptual approaches can be taken.
The first is the decompositional ap-
proach, which focuses on specific nutrients
and other chemical constituents offood.
The underlying premise of such an
approach is that single nutrients or chemi-
cals have a specific biologic effect on car-
cinogenesis and, further, that it is possible
to isolate this biologic activity.
This paper was presented at the President's
Cancer Panel Conference on Avoidable Causes of
Cancer held 7-8 April 1994 in Bethesda, Maryland.
Manuscript received 9 March 1995; manuscript
accepted 24 March 1995.
Address correspondence to Dr. Arthur Schatzkin,
Cancer Prevention Studies Branch, Division of Cancer
Prevention and Control, National Cancer Institute,
9000 Rockville Pike, EPN 211, Bethesda, MD 20892.
Telephone: (301) 496-8559. Fax: (301) 402-0553. E-
mail: schatzkaOdcpcepn.nci.nih.gov
Abbreviations used: AARP, American Association
of Retired Persons; IU, international units; kcal, kilo-
calories; mg, milligram; NCI, National Cancer Institute;
NIH, National Institutes of Health; PPT, Polyp
PreventionTral; WHI, Women's Health Initiative.
The alternative is the integrative
approach, which considers the effects of
whole foods cusines or food patterns
(cuisines). The underlying premise ofthis
approach is that people eat whole foods
containing hundreds ofindividual nutri-
ents or chemicals that interact in highly
complex ways-with one another and
other, possibly unknown, substances-to
influence carcinogenesis. It is therefore
difficult on both theoretical and practical
grounds to isolate the specific cancer-
related biologic activities ofsingle nutrients
orchemicals.
We can group major diet and cancer
hypotheses according to this framework, as
thefollowing examples show.
Nutrient-andChemical-based
Hypotheses
TheAntioxidantHypotheses. Antioxidants
include such substances as carotenoids,
vitamins C and E, and flavonoids (2).
Specific examples of these hypotheses
include 5-carotene and lung cancer (3),
and vitamin E in relation to prostate (4)
and large bowel cancer (5).
HypothesesInvolving OtherNutrients.
Examples include the possible protective
effects ofcalcium (6) and folic acid (7) on
large bowel carcinogenesis.
Hypotheses Implicating Various
Macronutrients. Specific examples of
macronutrient hypotheses include the
often researched and still unresolved rela-
tion ofdietary fat and breast cancer (8),
the more recently proposed link between
linolenic acid and prostate cancer (9), or
the (protective) association between dietary
fiber intake andlarge bowel cancer (10).
The Food Mutagen Hypothesis.
Heterocyclic amines, produced in high-tem-
perature cooking ofmeats, have been sug-
gested as factors in thegenesis oflarge bowel
malignancies (11).
Food- andCuisine-basedHypotheses
FoodsandFoodGroups. Several hypothe-
ses on the relations ofvarious foods and
food groups to cancer are under investiga-
tion. Red meat consumption, for example,
has been linked to large bowel cancer (12).
A protective effect ofvegetable and fruit
intake has been hypothesized for several
cancers (13). Possible cancer-preventive
roles forsoy-based products (14) and garlic
(15) have been proposed.
Dietary Patterns (Cuisines). It has
been hypothesized that an overall low-fat,
high-fiber, high-vegetable and -fruit eating
plan reduces the risk oflarge bowel (16)
and possibly other cancers, compared with
the more typical Western high-fat, low-
fiber, low-vegetable and -fruit fare. Some
have argued that a vegetarian diet reduces
cancer risk (17). In a similar vein, it has
been proposed that Mediterranean and
Asian cuisines, as opposed to U.S. or
Western European eating patterns, protect
against certain malignancies (18).
We now briefly review four types of
scientific investigation available to us for
advancing the diet and cancer field: meta-
bolic studies, animal studies, observa-
tional epidemiology, and randomized
controlled trials.
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Metabolic Studies
Metabolic (or clinical nutrition) studies
involve intensive, controlled supplement or
dietary interventions with a relatively small
number ofpeople. Noncancer (biomarker)
end points are used. Such studies can exam-
ine the effect offat or meat intake on blood
hormone levels (such as estrogens or andro-
gens) (19); the intake ofhigh-carotenoid-
containing foods or carotenoid supplements
in relation to blood or tissue carotenoid
levels (20); the impact ofa low-fat, high-
fiber, high-fruit and -vegetable eating plan
on fecal bile acids (21) or short-chain fatty
acids (22); or the influence ofalcohol con-
sumption on endogenous estrogens and
other hormones in women (23).
Metabolic studies have a number of
advantages. They can aid in refining our
dietary assessment questionnaires as well as
the databases underlying these instruments.
This is exemplified by recent studies ofthe
types and amounts of mutagenic sub-
stances produced by high-temperature
cooking ofvarious meats (24). Metabolic
studies can also demonstrate the relation of
blood or tissue nutrient levels to intake
(25) and thereby play a role in the devel-
opment of biological markers of dietary
intake. Still another advantage of these
investigations is the possibility ofinterven-
ing with well-defined diets. Finally, meta-
bolic studies, which can involve multiple
biomarker end points, may provide valu-
able insight into plausible mechanisms
underlying carcinogenesis.
A major limitation ofmetabolic studies
is the noncancer end points. The relation of
such end points to cancer and neoplasia is
not sufficiently clear to warrant conclusive
inferences about diet and cancer from these
studies (26). Studies, for example, dem-
onstrating an effect ofalcohol or dietary fat
on endogenous estrogens suggest that these
nutritional factors influence breast carcino-
genesis. For two reasons, however, such stud-
ies are less than conclusive when it comes to
establishing a causal connection between
the nutritional factors and breast cancer:
data establishing a direct relation between
blood estrogen levels and breast cancer are,
in fact, sparse at best (27); and even ifthe
evidence were strong that a relatively high
blood level ofestradiol increased breast can-
cer risk, one could not rule out the possibil-
ity that the nutritional factors affected some
other biologic intermediate that inhibited
breast carcinogenesis.
Animal Studies
In a similar vein, animal studies can also
enhance the biologic plausibility of diet
and cancer hypotheses. In particular,
investigators conducting such studies can
examine controlled diets, study cancer as
an explicit end point, integrate biomarkers
in animal models (creating a complete
exposure-intermediate end point-cancer
continuum) (28), and evaluate potential
chemopreventive agents as well as some
animal analogues ofdietary patterns.
Given the often major differences in
anatomy and physiology between labora-
tory animals and people, inferences from
animal models to human malignancy are
problematic. Animal studies, however, are
not without inferential value. Consistency
in diet-cancer relations across species and
tumor models lends confidence that the
relations hold in human populations.
Moreover, delineation of mechanisms in
many model systems can be useful in our
approach to studying cancer in humans.
For example, animal studies consistently
indicating effects ofdietary factors only on
late-stage events suggest conducting human
studies that focus on recent rather than
remote diet.
Observational Studies
It is because ofthe limitations ofmetabolic
and laboratory studies in making clear-cut
inferences to cancer in people that observa-
tional epidemiologic studies and clinical
trials are so important.
Observational investigations-the two
major types are case-control and cohort
studies-make several important contribu-
tions to the diet and cancer field. First,
these studies do have cancer as an explicit
end point. Second, they can look at expo-
sures oflong duration; i.e., dietary intake
over many years. Third, large epidemio-
logic studies permit the evaluation ofinter-
actions between dietary and other risk
factors. This is germane where another risk
factor like obesity tends to overwhelm and
obscure the weaker (but still important)
dietary factor association. Analyses ofdiet
and cancer in, for example, thin women
may therefore be particularly revealing.
Finally, observational epidemiologic studies
are increasingly integrating intermediate
biomarkers of carcinogenesis into their
design. Observational studies also have their
limitations, however, and some ofthese are
discussed in the following sections.
DietaryMeasurementError
Because eating habits are complex and
human recall imperfect, the assessment of
diet-related exposures is subject to con-
siderable measurement error. This error
generally tends to attenuate relative risks
and therefore makes it difficult to observe
true associations (29).
Although statistical methods are avail-
able both to estimate and adjust for mis-
classification (30), these methods are not
universally accepted (31) and the valida-
tion (calibration) studies required for the
statistical corrections can be quite expen-
sive. Furthermore, energy adjustment pro-
cedures continue to be controversial (32).
It may not be possible, for example, to dis-
tinguish specific effects offat from those of
total caloric intake (33), although it may
still be possible to derive practical overall
dietary recommendations.
Work remains to be done in refining
ourdietary assessment instruments-partic-
ularly in rather understudied population
subgroups-but it is unclearjust how much
better we can make these instruments. That
is why there is so much interest in biomark-
ers ofintake, but additional work is needed
to develop accurate biomarkers ofdietary
intake at the individual level.
DietaryHomogeneity
The lack ofdietary heterogeneity (the fact
that in a given study carried out in a speci-
fic geographic region for a particular food
or nutrient, people tend to eat somewhat
alike) may make it difficult to make rele-
vant comparisons between high and low
levels ofnutrients and foods. Investigators
have recently adopted some innovative
approaches to increase dietary heterogene-
ity. These include the investigation ofmul-
tiple ethnic groups (34) and countries (35)
and the implementation of a two-phase
sampling design that explicitly captures the
extremes ofintake distribution (36).
Conunding
Confounding (37) is a serious potential
problem in observational studies. People
who eat differently may also differ in
other ways related to carcinogenesis, and
it may not always be possible to capture
these other differences in our interviews
and questionnaires.
Recall andSelection Bias
Case-control studies are subject to both
recall and selection bias. Researchers have
recently attempted to evaluate the extent of
recall bias in case-control studies of diet
and cancer by means ofpre- and postdiag-
nosis assessments of persons developing
malignancies within the setting ofan ongo-
ing cohort study (38,39). To reduce the
likelihood ofselection bias, epidemiologists
have been developing a number ofinnova-
tive approaches to increase participation
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rates in case-control studies (40). The
case-control design remains valuable for
investigating emerging hypotheses (in a
relatively short time) and examining the
relatively rare malignancy lying beyond the
statistical reach of most cohort studies.
Because the cohort design largely circum-
vents recall and selection biases, several
large prospective cohort studies ofdiet and
cancer have been mounted around the
world in recent years.
Uncertaintyabout Relevant
TimeofExposure
Most epidemiologic studies of diet and
cancer have assessed recent diet. Such
assessments are appropriate if diet affects
cancer risk by acting at a relatively late
stage in the carcinogenic process or recent
diet is a reasonable proxy for cumulative
lifetime dietary exposure that is truly
related to cancer development. Interest is
growing in the possibility that early-life
diet influences subsequent cancer. Method-
ologic studies are needed to determine
whether early diet can be assessed with any
useful degree ofaccuracy (41).
Intervention Studies
Another major research tool in this area is
the randomized controlled trial (42). The
interventions adopted in trials may be one
oftwo types: supplements (vitamin pills or
fiber wafers, for example), or a comprehen-
sive eating plan (for example, one with
specific targets for fat, red meat, fiber, or
fruits and vegetables).
Trials have two distinct advantages.
First, because ofrandomization, confound-
ing is minimized. Second, because the
trialist devises a specific intervention for
comparison with the usual diet or nonsup-
plemented state, intake heterogeneity is
built into the trial design. The National
Cancer Institute (NCI)-sponsored Polyp
Prevention Trial (PPT) is an example of
this latter advantage (16). Whereas the
usual intake among middle-aged and older
persons in the United States (as reflected in
the PPT control group) is about 35% calo-
ries from fat, 8 to 10 g ofdietary fiber per
1000 kcal, and two to three daily servings
of fruits and vegetables, the specific goals
for the intervention group in the PPT are
20% calories from fat, 18 g of fiber per
1000 kcal/day, and five to eight servings of
fruits and vegetables daily.
Trials, however, do have limitations.
First, the intervention is generally of rela-
tively short duration and the effects of
much longer exposure to a given set of
dietary factors cannot be easily established in
a trial. Second, the intervention generally is
fixed for the duration ofthe trial and there
often is considerable uncertainty in select-
ing the proper dosage or administration
interval for a supplement study or the exact
components of an eating plan in a dietary
intervention. Third, dietary interventions,
as opposed to supplements, cannot be dou-
ble blind. If participants know they are
changing their diet, they could also be
changing other things related to cancer or
neoplasia as a result ofknowing about and
being in the intervention group. Fourth,
interventions are generally done only in
adults because dietary effects resulting from
earlier life exposure are difficult to test.
Finally, trials are faced with difficulties in
maintaining long-term adherence and are
relatively expensive.
Future trials will continue as much as
possible to make use ofthe factorial design,
which gives, in essence, two or more studies
for the price ofone (43). Trials likely will
increasingly use cancer precursors like ade-
nomatous polyps as end points, although
inferences from precursor studies are more
limited than those from studies with cancer
end points (44). Trials would also benefit
from advances in biologic monitoring of
intake as well as further development of
behavioral techniques to improve dietary
adherence. And, finally, there is increasing
discussion of the need for longer follow-
ups in nutritional chemoprevention and
dietary trials (45).
In summary, trials can be extremely
valuable in establishing causation and
providing a rational, scientific basis for
cancer prevention. However, they com-
prise only a part, albeit, an important one,
of an overall research program. They are
not a panacea.
Future Research for Major
Diet and Cancer Hypotheses
Let us briefly illustrate the above points
with reference to some key dietary hypothe-
ses for cancers of the large bowel, lung,
prostate, and breast.
Iarge Bowel Cancer
Data inconsistencies remain-with regard
to animal fat and red meat consumption,
for example-in observational epidemio-
logic studies oflarge bowel cancer. These
inconsistencies need to be examined in
other studies (46). Recent reports of an
inverse relationship between dietary folate
and colorectal cancer (47) are ofconsider-
able interest, but whether folate influences
large bowel carcinogenesis independently
or is merely a proxy for fruit and vegetable
intake remains to be determined. By inte-
grating susceptibility markers into epi-
demiologic studies, it may be possible to
increase observed relative risks among sus-
ceptible individuals (48). These suscepti-
bility markers might include family history
as well as genotypic and phenotypic char-
acterizations ofan individual's capacity to
metabolize carcinogens (49).
A number of adenomatous polyp
recurrence trials have been completed or
are under way around the world. These
include trials of vitamins (50), calcium
(51), fiber supplements (51,52), folic acid
(R Greenberg, personal communication),
and a low-fat, high-fiber, high-fruit and
-vegetable eating plan (16). Future polyp
trials might include interventions involving
reduced consumption of red meat or meat
cooked at high temperatures. Because
inferences from polyp trials to cancer are
not absolute, there is need to consider
polyp trial results together with the find-
ings from well-designed observational
studies with adequate intake range (44).
Two new large trials have large bowel
cancer as an explicit end point. The
Women's Health Study conducted by
Buring and Hennekens will examine the
effect of ,-carotene (50 mg every other
day), vitamin E (600 IU every other day),
and aspirin among some 40,000 post-
menopausal female health professionals 45
years ofage and older. This study employs
a 23 factorial design and evaluates the
three factors in relation to cardiovascular
end points as well as total cancer and can-
cers of the breast, lung, and colon. The
Women's Health Initiative (WHI), a very
large, ambitious National Institutes of
Health (NIH)-sponsored study of heart
disease, cancer, and osteoporosis among
women in the United States, will random-
ize 63,000 postmenopausal women aged
50 to 79 in its controlled clinical trial
component. The trial has three interven-
tions, although women can choose to be
randomized into two or three of the over-
lapping studies. The interventions include
a low-fat eating plan (with explicit empha-
sis on increasing consumption of fruits
and vegetables), hormone replacement
therapy, and calcium/vitamin D supple-
mentation. Forty-eight thousand women
will be randomized into the dietary com-
ponent of the study (19,200 in the inter-
vention arm, 28,800 in the control arm).
The trial will require 4 years for protocol
development and 9 years offollow-up. The
trial has 90% power to detect a reduction
ofapproximately 25% in the incidence of
colorectal cancer.
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LungCancer
There is much evidence from observational
epidemiologic studies as well as metabolic
and laboratory investigations suggesting
that n-carotene intake is inversely associ-
ated with lung cancer risk. The Alpha
Tocopherol-Beta Carotene Trial carried
out among 29,133 male Finnish smokers,
however, showed no protective effect forP-
carotene (4). This is an instance in which
results from one large, well-designed inter-
vention study raise questions about awhole
body of epidemiologic evidence. One
explanation for the disparity between the
epidemiologic and trial findings that war-
rants further study is that it is not -
carotene per se that protects against lung
cancer but rather other nutrients or foods
that are highly correlated with 1-carotene
intake (or blood levels).
Breast Cancer
The observational epidemiology of diet
and breast cancer has not been particularly
revealing. Further insight might emerge if
we are able in such studies to increase
dietary heterogeneity, either through
greater study population diversity or the
two-stage cohort construction strategy
being employed in the NCI-American
Association of Retired Persons (AARP)
Health Study (36). A successful imple-
mentation of the large-scale dietary trial in
the NIH-sponsored Women's Health
Initiative certainly would be informative.
Because of the large body of evidence
implicating reproductive hormones in
breast carcinogenesis (53), further meta-
bolic studies ofdiet and hormones will be
useful in conjunction with additional (and
larger) observational studies ofthe precise
relation of hormones to breast cancer.
There is the very interesting hypothesis that
pesticides enhance breast carcinogenesis
(54)-this is not a hypothesis about foods
or nutrients per se, but about potentially
carcinogenic substances carried in foods.
Prostate Cancer
Some interesting findings have emerged,
largely from observational studies, suggest-
ing that red meat, and particularly linolenic
acid, may increase prostate cancer risk (9)
and that vitamin E (4) or vitamin A (55)
may protect against this risk. More observa-
tional epidemiology is needed to confirm
these findings. Metabolic studies of, for
example, meat or linolenic acid in relation
to androgens may provide additional bio-
logic support for this hypothesis. And the
time may be at hand to conduct trials to
test these hypotheses further.
Additional Considerations in
Diet and Cancer Research
Dietary factors may well be important
in the etiology of other cancers, but the
evidence to date is even more limited than
that for the four sites we emphasized.
Valuable information on diet in relation
to cancers of, for example, the ovary and
pancreas may come from some of the
ongoing large prospective cohort studies
that will eventually yield substantial
numbers ofthese malignancies.
Both the decompositional and inte-
grative approaches to diet and cancer
are spawning new avenues of research.
Considerable attention recently has been
focused on the possible anticancer effects
of various nonnutritive constituents of
foods, including flavonoids and other
phytochemicals. Methodologic work is
currently under way to develop the assess-
ment instruments and databases necessary
for further investigations of these com-
pounds. From the integrative perspective,
innovative approaches for the analysis of
dietary data, especially ones taking into
account multiple nutrients and foods, are
greatly needed. There are, for example, no
standardized, readily interpretable meth-
ods for identifying dietary patterns. This
methodologic work on dietary patterns
will not only enhance epidemiologic
analyses and dietary intervention study
planning but may even be of value in
future animal studies.
Conclusions
In conclusion, diet and cancer hypotheses
are promising. But they remain just that-
hypotheses. As yet, nothing is proven.
Given the enormous public health impor-
tance of putative diet and cancer relations,
researchers in this area have a responsibility
to seek that proofas vigorously and rapidly
as possible.
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